Loading provider…
Loading provider…
Gynecologic Oncology Physician in Moreno Valley, CA
NPI: 1396776688HQ Phone
Get MD Robin's Phone Numberphone_androidMobile
Get MD Robin's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNE State Medical License
CA State Medical License
A novel approach to oral apoA-I mimetic therapy.
Authors: Alan Fogelman
Publication Date: 2013-02-02
Retraction Note: A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.
Authors: Richard Pietras, Sami Dwabe, Marianna Sarkissyan
Lead Sponsor: ImmunoGen, Inc.
Collaborators: Gynecologic Oncology Group
Intervention / Treatment: DRUG: Paclitaxel, DRUG: Topotecan, DRUG: Mirvetuximab soravtansine, DRUG: Pegylated liposomal doxorubicin
Lead Sponsor: GOG Foundation
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Cytology Specimen Collection Procedure
Lead Sponsor: Seagen Inc.
Collaborators: Genmab, Gynecologic Oncology Group, European Network of Gynaecological Oncological Trial Groups (ENGOT), Belgian Gynaecological Oncology Group
Intervention / Treatment: DRUG: tisotumab vedotin